Today's announcement was actually for PD1-Vaxx and not HER-Vaxx. It's my understanding is that PD1-Vaxx is based on the same delivery method as HER-Vaxx using B cells to provoke a vaccine/immune response but the difference is that the drugs target different sites in the cells.
So, IMU has 4 potentially major drugs in the pipeline (HER-Vaxx, PD1-Vaxx, CheckVacc and Vaxinnia). I believe today's announcement was more a reminder of the diversity of the pipeline and the broader application of the B cell platform.
If all 4 were to be a success, what price would you put on a company with 4 drugs that would snare a fair chunk of what is likely to be a $200 billion market by 2026? Plus further opportunities that could be developed if the B Cell Platform works as hoped.
- Forums
- ASX - By Stock
- Ann: New mimotope cancer vaccine results published
Today's announcement was actually for PD1-Vaxx and not HER-Vaxx....
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.3¢ |
Change
0.002(3.92%) |
Mkt cap ! $373.3M |
Open | High | Low | Value | Volume |
5.1¢ | 5.3¢ | 5.0¢ | $605.4K | 11.73M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 455000 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 1913821 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 105605 | 0.056 |
14 | 161948 | 0.055 |
3 | 73632 | 0.054 |
2 | 1311411 | 0.053 |
4 | 770652 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 100000 | 1 |
0.049 | 150121 | 1 |
0.050 | 140643 | 3 |
0.051 | 248015 | 1 |
0.052 | 1013816 | 7 |
Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |